| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 112.93B | 110.58B | 104.38B | 108.28B | 92.64B | 76.90B |
| Gross Profit | 34.47B | 33.94B | 31.16B | 33.73B | 29.14B | 23.98B |
| EBITDA | 19.99B | 19.06B | 15.71B | 16.89B | 13.52B | 10.73B |
| Net Income | 10.27B | 9.43B | 8.67B | 8.53B | 6.31B | 4.54B |
Balance Sheet | ||||||
| Total Assets | 145.76B | 152.99B | 140.78B | 135.36B | 122.58B | 108.21B |
| Cash, Cash Equivalents and Short-Term Investments | 41.42B | 44.90B | 42.45B | 46.90B | 48.75B | 47.62B |
| Total Debt | 1.95B | 755.00M | 133.00M | 219.00M | 0.00 | 0.00 |
| Total Liabilities | 24.28B | 29.83B | 27.81B | 30.23B | 28.24B | 21.53B |
| Stockholders Equity | 121.48B | 123.15B | 112.97B | 105.13B | 94.34B | 86.68B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.33B | -2.60B | -1.28B | 5.60B | 7.86B |
| Operating Cash Flow | 0.00 | 16.01B | 11.97B | 9.12B | 9.76B | 10.64B |
| Investing Cash Flow | 0.00 | -10.98B | -12.31B | -11.20B | -9.66B | -3.74B |
| Financing Cash Flow | 0.00 | -4.90B | -4.15B | -2.50B | -2.36B | -1.69B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥359.37B | 5.46 | 9.34% | 4.27% | -0.48% | -35.29% | |
79 Outperform | ¥346.79B | 14.16 | 9.59% | 3.91% | 0.87% | 16.71% | |
76 Outperform | ¥446.33B | 17.67 | 6.52% | 1.82% | 3.25% | -11.31% | |
74 Outperform | ¥163.59B | 14.73 | ― | 2.84% | 6.06% | 19.76% | |
74 Outperform | ¥301.27B | 9.05 | 5.47% | 3.41% | 2.60% | 9.50% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥754.98B | 12.79 | 2.01% | 3.82% | -4.63% | -65.11% |